Effects of Hepatic Artery Chemoembolization Using Cisplatin-lipiodol Suspension with Gelatin Sponge Particles on Swine Liver

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 10, 2009, Pages 1359-1364

  Sahara, Shinya ^a   Tanihata, Hirohiko ^a   Sato, Morio ^a   Kawai, Nobuyuki ^a   Takasaka, Isao ^a   Minamiguchi, Hiroyuki ^a   Nakai, Motoki ^a   Sonomura, Tetsuo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GELATIN SPONGE; IODINATED POPPYSEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOEMBOLIZATION; CONTROLLED STUDY; HEPATIC ARTERY; LIVER NECROSIS; LIVER PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; SWINE; VENOUS BLOOD;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOSTATICS; IODIZED OIL; LIVER; SUSPENSIONS; SWINE;

EID: 70349469581     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.06.028     Document Type: Article

References (28)

1. Doyon D., Mouzon A., Jourde A.M., et al. L'embolisation arterielle hepatique dans les tumoeurs malignes du foie. Ann Radiol 17 (1974) 593-603 [French]
2. Goldstein H.M., Wallace S., Anderson J.H., et al. Transcatheter occlusion of abdominal tumors. Radiology 120 (1976) 539-545
3. Yamada R., Nakatsuka K., Nakamura K., et al. Transcatheter arterial embolization therapy in unresectable hepatoma-experiences in 15 cases. Acta Hepatoligica Jpn 20 (1979) 595-603
4. Nakakuma K., Tashiro S., Hiraoka T., et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 52 (1983) 2193-2200
5. Kanematsu T., Inokuchi K., Sugimachi K., et al. Selective effects of Lipiodolized antitumor agents. J Surg Oncol 25 (1984) 218-226
6. Nakamura H., Hashimoto T., Oi H., et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170 (1989) 783-786
7. Uchida H., Ohishi H., Matsuo N., et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13 (1990) 140-145
8. Ohishi H., Uchida B., Yoshimura H., et al. Hepatocellular carcinoma detected by iodized oil. Radiology 154 (1985) 25-29
9. Matsui O., Kadoya M., Yoshikawa J., et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188 (1993) 79-83
10. Konno T., Maeda H., Iwai K., et al. Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 19 (1983) 1053-1065
11. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
12. Chang J.M., Tzeng W.S., Pan H.B., et al. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. Cancer 74 (1994) 2449-2453
13. Sasaki Y., Imaoka S., Kasugai H., et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60 (1987) 1194-1203
14. Shibata J., Fujiyama S., Sato T., et al. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64 (1989) 1586-1594
15. Beppu T., Ohara C., Yamaguchi Y., et al. A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil. Cancer 68 (1991) 2555-2560
16. Maeda S., Shibata J., Fujiyama S., et al. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma. Hepatogastroenterology 50 (2003) 809-913
17. Kamada K., Nakanishi T., Kitamoto M., et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol 12 (2001) 847-854
18. Kasugai H., Kojima J., Tatsuta M., et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 97 (1989) 965-971
19. Ichida T., Kato M., Hayakawa A., et al. Therapeutic effect of a CDDP-epirubicin-lipiodol emulsion on advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 33 (1994) 74-78
20. Brown D.B., Gould J.E., Gervais D.A., et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18 (2007) 1469-1478
21. Getty R. The anatomy of the domestic animals (1975), WB Saunders, Philadelphia 1256-1282
22. Miller M.E. Anatomy of the dog (1969), WB Saunders, Philadelphia 699-706
23. Arvidsson D., Svensson H., and Haglund U. Laser-Doppler flowmetry for estimating liver blood flow. Am J Phsiol 254 (1988) G471-G476
24. Fujiyama S., Shibata J., Maeda S., et al. Phase 1 clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol. Br J Cancer 89 (2003) 1614-1619
25. Sakuma H., Kinami Y., Sekino H., et al. Blood kinetics of free-platinum in CDDP hepato-arterial injection therapy. Jpn J Cancer Chemother 18 (1991) 1357-1362
26. Sato M., Yamada R., Uchida B., et al. Effects of hepatic artery embolization with lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 16 (1993) 348-354
27. Masuda M. Evaluation of basic and clinical study on effect of anticancer drugs of lipiodol in chemoembolization on liver tissue. J Wakayama Med Soc 53 (2002) 185-192
28. Hihara T. Early influence of intraarterial administration of cisplatin-lipiodol suspension (CLS) on the liver and kidneys. J Yamanashi Med Soc 7 (1992) 67-78